Salem Investment Counselors’s CRISPR Therapeutics CRSP Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$25.4K	Buy	+535	New	+$28.2K	﹤0.01%	707
2025 Q4	–	Sell	-302	Closed	-$19.6K	–	556
2025 Q3	$19.6K	Hold	302	–	–	﹤0.01%	747
2025 Q2	$14.7K	Sell	302 -550	-65%	-$21.3K	﹤0.01%	784
2025 Q1	$29K	Hold	852	–	–	﹤0.01%	662
2024 Q4	$33.5K	Sell	852 -925	-52%	-$43.7K	﹤0.01%	647
2024 Q3	$83.5K	Buy	1,777 +2	+0.1%	+$101	﹤0.01%	480
2024 Q2	$95.9K	Hold	1,775	–	–	﹤0.01%	455
2024 Q1	$121K	Sell	1,775 -30	-2%	-$2.15K	﹤0.01%	427
2023 Q4	$113K	Hold	1,805	–	–	﹤0.01%	426
2023 Q3	$81.9K	Buy	1,805 +1,775	+5,917%	+$91.7K	﹤0.01%	450
2023 Q2	$1.69K	Buy	+30	New	+$1.7K	﹤0.01%	1018
2017 Q1	–	Sell	-650	Closed	-$13K	–	560
2016 Q4	$13K	Buy	+650	New	+$12.1K	﹤0.01%	476